Xevant

Xevant

Real-time PBM data analytics platform

Overview

Xevant provides data analytics tailored for the pharmacy benefit management (PBM) sector to help PBMs, health plans, TPAs, and broker organizations control pharmacy spend. Its platform automates data analyses and monitors data in real time to surface hidden cost drivers, delivering actionable insights and alerts, while its services include system implementation, customization, training, and ongoing support. The product stands out by offering a turnkey, automated analytics solution combined with hands-on setup and client support, focused specifically on PBM data. The goal is to reduce overall pharmacy spend, improve patient outcomes, and boost client satisfaction and retention through data-driven optimization.

Significant Headcount Growth

About Xevant

Simplify's Rating
Why Xevant is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Enterprise Software

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$3.1M

Headquarters

Draper, Utah

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Follow-on investment from HCAP Partners fuels growth since February 2024.
  • Ivím Health partnership launches Ivím at Work weight loss program.
  • 2023 Drug Trend Report positions Xevant as pharmacy insights leader.

What critics are saying

  • Inovalon crushes Xevant via scale after Relay Health acquisition.
  • CVS Caremark bundles AI analytics into PBM contracts by 2025.
  • Clarify Health poaches clients post-$100M Series D March 2026.

What makes Xevant unique

  • VerX AI platform prevents pharmacy waste via real-time PBM routing.
  • Biosimilar Dashboard accelerates adoption, cuts biologic drug spend.
  • Named 2025 Modern Healthcare Best in Business for AI analytics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$3.1M

Meets

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Meet Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$3.1M
Xevant

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Disability Insurance

Remote Work Options

Hybrid Work Options

Unlimited Paid Time Off

Parental Leave

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

2%

2 year growth

8%
U2FX
Jan 29th, 2026
Xevant Named a 2025 Modern Healthcare Best in Business Company for AI

Xevant named a 2025 Modern Healthcare Best in Business company for AI. Xevant, a leader in real-time pharmacy benefits intelligence, today announced it has been named a 2025 Modern Healthcare Best in Business company in the Artificial Intelligence (AI) category. The recognition honors healthcare suppliers and technology partners whose innovations delivered measurable impact across the healthcare ecosystem in 2025. U2Fx.com Nov 10, 2025 0 10 U2Fx.com Nov 30, 2025 0 12 U2Fx.com Oct 9, 2025 0 11 U2Fx.com Sep 15, 2025 0 96 U2Fx.com Oct 3, 2025 0 82 U2Fx.com Nov 26, 2025 0 80 U2Fx.com Oct 5, 2025 0 78

Xevant
Jun 11th, 2025
Xevant Launches VerX: A Bold Strike Against the Rx Cost Crisis

LEHI, Utah - (BUSINESS WIRE) - Xevant, a leader in real-time pharmacy benefits AI and analytics, today announced the launch of VerX (pronounced "Vair-ex"), a powerful new platform that redefines how pharmacy benefits are optimized, managed, and controlled.

Xevant
Apr 25th, 2025
Xevant Unveils 2025 Drug Price Inflation White Paper: A Data-Driven Look at Rising Pharmaceutical Costs and Future Implications

LEHI, Utah, April 25, 2025 - (BUSINESS WIRE) - Xevant, a leading provider of real-time data analytics for pharmacy benefit management, today announced the release of its 2025 Drug Price Inflation White Paper, providing key insights into the ongoing surge in pharmaceutical prices and what it means for payers, employers, and pharmacy benefit managers (PBMs).

Life Science Connect
Mar 7th, 2025
Xevant Introduces The All-New Biosimilar Dashboard, A Real-Time Analytics Tool To Accelerate Biosimilar Adoption And Reduce Unnecessary Biologic Drug Spend

Xevant introduces the all-new Biosimilar Dashboard, A Real-Time Analytics tool to accelerate biosimilar adoption and reduce unnecessary biologic Drug spend.

ClaimLinx
Oct 22nd, 2024
ClaimLinx is partnering with IVIM to lower healthcare costs

Xevant and Ivím Health are partnering to launch a corporate medical weight loss program called Ivím at Work.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Xevant right now.

Find jobs on Simplify and start your career today

We update Xevant's jobs every few hours, so check again soon! Browse all jobs →